首页> 美国卫生研究院文献>Age >Circulating Lp-PLA2 activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapy
【2h】

Circulating Lp-PLA2 activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapy

机译:不使用激素替代疗法的超重/肥胖绝经后妇女循环中的Lp-PLA2活性与氧化应激和细胞因子有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Controversy remains regarding whether there is an association between circulating lipoprotein-associated phospholipase A2 (Lp-PLA2), cytokines, and oxidative stress in healthy postmenopausal women. We investigated the influence of age on Lp-PLA2 activity in postmenopausal women not using hormone therapy and the relationship of Lp-PLA2 enzyme activity to serum cytokine levels and oxidative stress indices. Normal weight (n = 1284) and overweight/obese (n = 707) postmenopausal women not using hormone therapy were categorized into five age groups: 50–54, 55–59, 60–64, 65–69, and 70–89 years. Overweight-obese women showed higher plasma Lp-PLA2 activity, urinary 8-epi-prostaglandin F2α (8-epi-PGF2α), serum interleukin (IL)-6, and smaller LDL particles than normal-weight women after adjusting for age, years postmenopause, smoking, drinking, blood pressure, glucose, insulin, lipid profiles, BMI, and waist circumference. Overweight/obese women 70–89 years old showed higher Lp-PLA2 activity than those aged 50–54 years, whereas no significant difference in Lp-PLA2 activity existed across normal-weight female age groups. Overweight/obese women aged ≥65 years showed higher Lp-PLA2, oxidized LDL (ox-LDL), IL-6, and 8-epi-PGF2α than age-matched normal-weight controls. Overweight/obese women aged ≥70 years had higher ox-LDL levels than those aged 50–59, and overweight/obese women aged 65–89 showed higher IL-6 and 8-epi-PGF2α. There were strong positive correlations between Lp-PLA2 and ox-LDL (r = 0.385, P < 0.001), Lp-PLA2 and IL-6 (r = 0.293, P < 0.001), and ox-LDL and IL-6 (r = 0.303, P < 0.001) in overweight/obese women; however, these relationships were weak in normal-weight women. These results suggest that aging and obesity-related oxidative and inflammatory mediators are associated with Lp-PLA2 activity in overweight/obese postmenopausal women not using hormone therapy.
机译:关于健康绝经后妇女的循环脂蛋白相关磷脂酶A2(Lp-PLA2),细胞因子和氧化应激之间是否存在关联仍存在争议。我们调查了年龄对未使用激素疗法的绝经后妇女Lp-PLA2活性的影响以及Lp-PLA2酶活性与血清细胞因子水平和氧化应激指数的关系。不使用激素疗法的绝经后正常体重(n over = 1284)和超重/肥胖(n = 707)分为五个年龄段:50-54岁,55-59岁,60-64岁,65-69岁和70-89岁。调整了年龄,岁数后,超重女性的血浆Lp-PLA2活性,尿液中的8-epi-前列腺素F2α(8-epi-PGF2α),血清白介素(IL)-6和LDL颗粒均较正常体重的女性高。绝经后,吸烟,饮酒,血压,葡萄糖,胰岛素,血脂,BMI和腰围。 70-89岁的超重/肥胖妇女的Lp-PLA2活性高于50-54岁的妇女,而在正常体重的女性年龄组中,Lp-PLA2的活性无显着差异。年龄≥65岁的超重/肥胖妇女的Lp-PLA2,氧化型LDL(ox-LDL),IL-6和8-epi-PGF2α高于年龄相称的正常体重对照。 ≥70岁的超重/肥胖女性的ox-LDL水平高于50-59岁的人群,而65-89岁的超重/肥胖女性的IL-6和8-epi-PGF2α更高。 Lp-PLA2与ox-LDL(r = 0.385,P <0.001),Lp-PLA2和IL-6(r = 0.293,P <0.001)与ox-LDL和IL-6(r超重/肥胖妇女== 0.303,P 0.001);但是,这些关系在体重正常的女性中较弱。这些结果表明,在未使用激素疗法的超重/肥胖绝经后妇女中,衰老和肥胖相关的氧化和炎症介质与Lp-PLA2活性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号